Abstract
Safety and Efficacy of Recombinant Factor XIII (FXIII) in Patients with Congenital FXIII A-Subunit Deficiency, Results from the Mentor™2 Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have